news
FDA grants approval of Besponsa for acute lymphoblastic leukaemia
The FDA has approved Besponsa for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia...
List view / Grid view
Drug Supply Chain
news
Bayer receives EU approval for Regorafenib
Bayer have announced the European Commission has granted marketing authorisation for Stivarga...
news
Puration announces strategy to become cannabis market leader
Puration plans to displace pharmaceutical market leader, GW Pharmaceuticals, as part of strategy to grow US cannabis market
news
Arvato Systems signs deal with SecurMed UK to deliver medicines verification
SecurMed UK, the UK Medicines Verification Organisation, is entering into a Letter of Intent with Arvato Systems as its IT blueprint service provider.
article
Drug and alcohol testing: An expanding market
The demand for drug and alcohol testing in the UK is at an all-time high and the market is growing rapidly, says Livingstone's Barry Sheehan...
news
FDA approves cryopreserved formulation of ReNeuron’s candidate
The FDA has approved the cryopreserved formulation of ReNeuron’s human retinal progenitor cell (hRPC) therapeutic candidate...
news
Health leaders launch Alliance for Transparent & Affordable Prescriptions
Health leaders announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.
article
Packaging In-Depth Focus 2017
FMD and supply chain security; Strategic aspects of change control for pharmaceutical packaging systems; and does the Falsified Medicines Directive lead to a European pack coding guideline?
article
Understanding today’s drug pricing environment
In a healthcare world that experiences a plethora of high-cost new therapies coming to market in parallel with price increases for existing speciality drugs, pharmaceutical companies are having to move away from traditional pricing models that are largely based on demand and what the market will bear. At the same…
article
CEIV Pharma: Industry cooperation that is taking off
4 May 2016 | By Ricardo Aitken and Michal Wielgus, IATA Consulting
Several air transport industry stakeholders and regulators have joined forces to create the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) programme. This joint effort aims to effectively help reverse the current lack of standardisation, compliance and transparency currently afflicting the pharmaceutical air transport supply chain, via…
news
Systech to host Uniquity Europe global brand protection conference
8 March 2016 | By Systech International
Global brands focus on consumer safety at Amsterdam conference...
whitepaper
eBook: Pharma Serialisation – Where to Begin
By the end of 2018, 75% of the world’s prescription medications will be protected by legislation - this eBook explains the basic fundamentals of pharma serialisation...
news
CPhI report highlights potential risks in biologics supply chain outsourcing
15 October 2015 | By Victoria White
CPhI highlights these risks in the fourth and final section of its 2015 annual report, The Outsourcing perspective...
article
Drugs shortages are finally being addressed
Maintaining the security of the supply chain for drug products is a significant responsibility to ensure the sustained availability of safe medicines...
news
Healthcare firms need to move away from a one-size-fits-all mindset when it comes to supply chains, says Crimson & Co
11 June 2015 | By Victoria White
Healthcare firms have to be prepared to break with tradition and move away from employing a one-size-fits-all approach with existing suppliers...
